Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Agammaglobulinemia

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Agammaglobulinemia:

Pubmed Logo
Clinical Characteristics and Genotype-phenotype Correlation in 62 Patients with X-linked Agammaglobulinemia.
INTRODUCTION: X-linked agammagobulinemia (XLA) is a primary...
12th November, 2009
Department of Paediatrics and Adolescent Medicine, The University of Hong J Clin Immunol. 2009 Nov 11.
DOI Direct Link
Sustained virologic response following HCV eradication in two brothers with X-linked agammaglobulinaemia.
X-linked agammaglobulinaemia (XLA) is a humoral immunodeficiency syndrome...
29th October, 2009
Department of Gastroenterology, University College Hospital Galway, World J Gastroenterol. 2009 Aug 21;15(31):3944-6.
NF-kappaB regulates the transcription of protein tyrosine kinase Tec.
The tyrosine kinase expressed in hepatocellular carcinoma (Tec) is a...
22nd October, 2009
Department of Laboratory Medicine, Clinical Research Center, Karolinska FEBS J. 2009 Oct 16.
DOI Direct Link
Autoimmunity in common variable immunodeficiency.
Common variable immunodeficiency (CVID) is the most common clinically...
22nd October, 2009
Mount Sinai Medical Center, New York, NY 10029, USA. Curr Allergy Asthma Rep. 2009 Sep;9(5):347-52.
Osteopetrosis--more than only a disease of the bone.
BACKGROUND: Immunodeficiency with a thymoma (Good''''s syndrome) is a rare...
21st October, 2009
Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Am J Hematol. 2009 Aug;84(8):469-70.
DOI Direct Link

View more research publications.

Agammaglobulinemia Clinical Trials:

Clinical Trials Logo
Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)

Agammaglobulinemia Patents:

USPTO Logo
US Patent No.Title
7452538 Death domain containing receptor 4 antibodies and methods
7501410 Methods of inhibiting BTK and SYK protein kinases
7504105 Treatment using antibodies to cytokine receptor common gamma chain like
7504254 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes
7504481 TRP channel family member, LTRPC3 polypeptides

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Agammaglobulinemia scientists - we have details of around 546 individuals working on Agammaglobulinemia .


This page has been viewed 530 times
Recent Search Terms used to find this page: Agammaglobulinemia 2009 | agammaglobulinemia research | preimplantation genetic diagnosis for x-linked agammaglobulinemia | agammaglobulinemia | clinical trials for agammaglobulinemia | clinical trials for agammaglobulinemia | clinical trials for agammaglobulinemia | lab nocivelli | incidence of agammaglobulinemia in US | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Agammaglobulinemia across BioPortfolio, or for Agammaglobulinemia Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.